McKesson CorporationMCKEarnings & Financial Report
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company.
Revenue
$95.3B
Gross Profit
$3.3B
Operating Profit
$1.2B
Net Profit
$879.0M
Gross Margin
3.4%
Operating Margin
1.3%
Net Margin
0.9%
YoY Growth
17.8%
EPS
$6.95
Financial Flow
McKesson Corporation Q3 2025 Financial Summary
McKesson Corporation reported revenue of $95.3B for Q3 2025, with a net profit of $879.0M (0.9% margin). Cost of goods sold was $92.0B, operating expenses totaled $2.1B.
Key Financial Metrics
| Total Revenue | $95.3B |
|---|---|
| Net Profit | $879.0M |
| Gross Margin | 3.4% |
| Operating Margin | 1.3% |
| Report Period | Q3 2025 |
McKesson Corporation Annual Revenue by Year
McKesson Corporation annual revenue history includes year-by-year totals (for example, 2025 revenue was $359.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $359.1B |
| 2024 | $309.0B |
| 2023 | $276.7B |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $76.36B | $79.28B | $93.65B | $95.29B | $90.82B | $97.83B | $103.15B | $106.16B |
| YoY Growth | 10.8% | 6.4% | 21.3% | 17.8% | 18.9% | 23.4% | 10.1% | 11.4% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $67.44B | $71.67B | $72.43B | $71.08B | $75.14B | $81.31B | $84.16B | $84.19B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $-1.97B | $-1.75B | $-3.02B | $-3.08B | $-2.07B | $-1.97B | $-1.74B | $-1.30B |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.15B | $-1.38B | $2.10B | $-2.38B | $7.75B | $-918.0M | $2.42B | $1.23B |
Other Health Care Companies
CAH
Cardinal Health
Revenue
$65.6B
Net Profit
$467.0M
COR
Cencora
Revenue
$85.9B
Net Profit
$559.6M
HSIC
Henry Schein
Revenue
$3.3B
Net Profit
$101.0M
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B
BAX
Baxter International
Revenue
$3.0B
Net Profit
$-1.1B
BDX
Becton Dickinson
Revenue
$5.3B
Net Profit
$382.0M